How many institutional investors hold TEVA?

7 tracked institutional investors disclosed a position in TEVA (TEVA PHARMACEUTICAL INDUSTRIES) in their most recent 13F filing.

Who is the largest institutional holder of TEVA?

Stanley Druckenmiller, Duquesne Family Office, holds the largest disclosed position in TEVA, valued at $335M.

Where does this TEVA ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

TEVA — TEVA PHARMACEUTICAL INDUSTRIES

Name: TEVA PHARMACEUTICAL INDUSTRIES (TEVA) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About TEVA PHARMACEUTICAL INDUSTRIES (TEVA)

TEVA PHARMACEUTICAL INDUSTRIES (TEVA) appears in the most recent 13F filings of 7 tracked institutional investors. The largest disclosed position is held by Stanley Druckenmiller (Duquesne Family Office), valued at $335M. Across recent filings, tracked investors recorded 4 new positions, 1 increased, 5 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in TEVA

/100

Mixed Activity

Added / Increased5

Reduced5

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track TEVA

/100

Moderate Interest

7investors

Several tracked investors have exposure.

UndiscoveredCrowded

151015+

TEVA Ownership Composition

How TEVA PHARMACEUTICAL INDUSTRIES is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

85% of tracked value

Institutions

tracked investors

Total Reported

$330.8M

combined 13F value

Other84.9%
Hedge Funds14.5%
Growth Funds0.6%

Other(5)

84.9%

Hedge Funds(1)

14.5%

Growth Funds(1)

0.6%

Tracked investors reporting TEVA

Investor	Firm	Shares	Market value	% of portfolio	As of
Stanley Druckenmiller	Duquesne Family Office	2.4M	$71.6M	2.12%	Mar 31, 2026
Ken Griffin	Citadel Advisors	3.2M	$96.6M	0.02%	Mar 31, 2026
Izzy Englander	Millennium Management	2.5M	$75.7M	0.03%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	1.6M	$48M	0.06%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	1.1M	$34M	0.15%	Mar 31, 2026
Cathie Wood	ARK Investment Management	68.3K	$2.1M	0.02%	Mar 31, 2026
David Einhorn	Greenlight Capital	268.5K	$2.8M	0.14%	Dec 31, 2023

Stanley DruckenmillerMar 31, 2026
Duquesne Family Office
Shares
2.4M
Value
$71.6M
% Portfolio
2.12%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
3.2M
Value
$96.6M
% Portfolio
0.02%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
2.5M
Value
$75.7M
% Portfolio
0.03%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
1.6M
Value
$48M
% Portfolio
0.06%
Ray DalioMar 31, 2026
Bridgewater Associates
Shares
1.1M
Value
$34M
% Portfolio
0.15%
Cathie WoodMar 31, 2026
ARK Investment Management
Shares
68.3K
Value
$2.1M
% Portfolio
0.02%
David EinhornDec 31, 2023
Greenlight Capital
Shares
268.5K
Value
$2.8M
% Portfolio
0.14%

Recent activity

Investor	Action	Δ %	Current value	Filing date
David Einhorn	New	—	$2.8M	Feb 14, 2024
Stanley Druckenmiller	Reduced	-59.53%	$71.6M	May 15, 2026
Ray Dalio	Increased	49.64%	$34M	May 15, 2026
Cathie Wood	Reduced	-35.05%	$2.1M	May 12, 2026
Ken Griffin	Sold	-100.00%	$0	Feb 17, 2026
Stanley Druckenmiller	Reduced	-64.60%	$183.4M	Feb 17, 2026
Ray Dalio	Reduced	-12.80%	$23.5M	Feb 13, 2026
Cathie Wood	Reduced	-11.45%	$3.3M	Feb 11, 2026
Stanley Druckenmiller	New	—	$335.2M	Nov 14, 2025
Ray Dalio	New	—	$17.5M	Nov 13, 2025
Cathie Wood	New	—	$2.4M	Nov 12, 2025

David Einhorn
New
$2.8MFeb 14, 2024
Stanley Druckenmiller
Reduced
$71.6M(-59.53%)May 15, 2026
Ray Dalio
Increased
$34M(49.64%)May 15, 2026
Cathie Wood
Reduced
$2.1M(-35.05%)May 12, 2026
Ken Griffin
Sold
$0(-100.00%)Feb 17, 2026
Stanley Druckenmiller
Reduced
$183.4M(-64.60%)Feb 17, 2026
Ray Dalio
Reduced
$23.5M(-12.80%)Feb 13, 2026
Cathie Wood
Reduced
$3.3M(-11.45%)Feb 11, 2026
Stanley Druckenmiller
New
$335.2MNov 14, 2025
Ray Dalio
New
$17.5MNov 13, 2025
Cathie Wood
New
$2.4MNov 12, 2025

Frequently asked questions

How many institutional investors hold TEVA?: 7 tracked institutional investors disclosed a position in TEVA (TEVA PHARMACEUTICAL INDUSTRIES) in their most recent 13F filing.
Who is the largest institutional holder of TEVA?: Stanley Druckenmiller, Duquesne Family Office, holds the largest disclosed position in TEVA, valued at $335M.
Did institutional ownership of TEVA increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 1 increased, 5 reduced, and 1 fully exited TEVA.
Where does this TEVA ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.